SCHEMBL803650

SCHEMBL803650

CCOCCOC(=O)[C@@H](OC(=O)C[N+]1=CC(N)C=C1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
EPHX2 P34913 2/20 0.33
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
CYP1A2 P05177 2/20 0.32
LMNA P02545 1/20 0.32
CYP2D6 P10635 1/20 0.32
CHRM1 P11229 2/20 0.31
CHRM3 P20309 2/20 0.31
CYP3A4 P08684 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803800 1.00 KDM4E (0.35) KDM4EEPHX2ALDH1A1SMN1; SMN2MEN1
SCHEMBL803819 0.90 MMP8 (0.38) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL803648 0.88 ALDH1A1 (0.38) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL803595 0.88 ALDH1A1 (0.38) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL803798 0.88 NPC1 (0.40) KDM4EALDH1A1SMN1; SMN2LMNACYP3A4
SCHEMBL803647 0.88 NPC1 (0.40) KDM4EALDH1A1SMN1; SMN2LMNACYP3A4
SCHEMBL803817 0.85 KMT2A (0.39) ALDH1A1MEN1KMT2A
SCHEMBL803594 0.85 KMT2A (0.39) ALDH1A1MEN1KMT2A
SCHEMBL803596 0.76 CYP1A2 (0.31) ALDH1A1CYP1A2
SCHEMBL803821 0.75 L3MBTL1 (0.34) MEN1KMT2ACYP1A2LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785655-B2 Ionic liquid solvents DUBLIN CITY UNIVERSITY (IE) 2014-07-22 US disclosed
US-20120071661-A1 Ionic Liquid Solvents DUBLIN CITY UNIVERSITY (IE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071661-A1 Ionic Liquid Solvents EBP, PAICS, HACD3 KDM4E 2490/4885EPHX2 265/4885ALDH1A1 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.